There is provision in the UK for supplementary protection for a medicinal product in the form of a supplementary protection certificate (SPC).
In October 2020, India and South Africa asked the WTO to waive Sections 1, 4, 5 and 7 of Part II of TRIPS which cover IP rights for technology relating to the prevention, containment, and treatment of COVID-19. A final decision on this proposal is expected early 2021.
How will your UK and European intellectual property rights be affected by Brexit? Who can represent your interests in the UK and Europe?
High Court ruling in trade mark infringement case rules that Halewood's use of the American Eagle mark would cause detriment to the distinctive charater of the Eagle Rare brand.
The EPO and UKIPO agree an inventor must be a natural person but offer different reasons for refusing to grant patent application to AI machine DABUS.
“Pay-for-delay” agreements have been considered by the CJEU for the first time in the case Generics UK vs Competition and Markets Authority (CMA), with the CJEU ruling that such agreements may contravene competition law.
The European Patent Office (EPO) has announced a pilot project to trial opposition hearings by video conference, which will run until 30 April 2021.
The World Health Organisation has now called for a broader sharing of knowledge, data and intellectual property in their Solidarity Call to Action, stating that "the single most important priority of the global community is to stop the COVID-19 pandemic in its tracks"
The recent Board of Appeal decision T1385/15 concerns European patent EP1865998, which claimed a disinfectant agent for killing bacterial, viruses and fungi through mechanical disinfection of a surface.
Hosted by Insider Media and sposored by AdamsonJones, the Leicestershire Economic Forum, Tuesday 27th April 2021, will look at how companies can make the most of opportunities in growing sectors such as medtech, digital innovation, low carbon, advanced manufacturing and logistics.